Inflammation and the Peritoneal Membrane: Causes and Impact on Structure and Function during Peritoneal Dialysis
Open Access
- 25 March 2012
- journal article
- review article
- Published by Wiley in Mediators of Inflammation
- Vol. 2012, 1-4
Abstract
Peritoneal dialysis therapy has increased in popularity since the end of the 1970s. This method provides a patient survival rate equivalent to hemodialysis and better preservation of residual renal function. However, technique failure by peritonitis, and ultrafiltration failure, which is a multifactorial complication that can affect up to 40% of patients after 3 years of therapy. Encapsulant peritoneal sclerosis is an extreme and potentially fatal manifestation. Causes of inflammation in peritoneal dialysis range from traditional factors to those related to chronic kidney diseaseper se, as well as from the peritoneal dialysis treatment, including the peritoneal dialysis catheter, dialysis solution, and infectious peritonitis. Peritoneal inflammation generated causes significant structural alterations including: thickening and cubic transformation of mesothelial cells, fibrin deposition, fibrous capsule formation, perivascular bleeding, and interstitial fibrosis. Structural alterations of the peritoneal membrane described above result in clinical and functional changes. One of these clinical manifestations is ultrafiltration failure and can occur in up to 30% of patients on PD after five years of treatment. An understanding of the mechanisms involved in peritoneal inflammation is fundamental to improve patient survival and provide a better quality of life.Keywords
This publication has 24 references indexed in Scilit:
- Risk Factors Associated with Encapsulating Peritoneal Sclerosis in Dutch Eps StudyPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2011
- Effects of icodextrin on the peritoneal membraneNephrology Dialysis Transplantation, 2010
- Does endothelin B receptor deficiency ameliorate the induction of peritoneal fibrosis in experimental peritoneal dialysis?Nephrology Dialysis Transplantation, 2009
- Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studiesNephrology Dialysis Transplantation, 2008
- High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cellsNephrology Dialysis Transplantation, 2007
- Peritoneal Changes after Exposure to Sterile Solutions by CatheterJournal of the American Society of Nephrology, 2007
- Simulations of osmotic ultrafiltration failure in CAPD using a serial three-pore membrane/fiber matrix modelAmerican Journal of Physiology-Renal Physiology, 2007
- Biocompatibility of Peritoneal Dialysis Fluid and Influence of Compositions on Peritoneal FibrosisTherapeutic Apheresis and Dialysis, 2006
- Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemiaNephrology Dialysis Transplantation, 2006
- Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacityKidney International, 1990